Chemotherapy of the transplanted KHT fibrosarcoma in mice.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001681:Biological Assay; D002460:Cell Line; D002470:Cell Survival; D002471:Cell Transformation, Neoplastic / Q000187:drug effects; D003520:Cyclophosphamide / Q000627:therapeutic use; D003561:Cytarabine / Q000627:therapeutic use; D004357:Drug Synergism; D005260:Female; D005354:Fibrosarcoma / Q000188:drug therapy*; D006412:Hematopoietic Stem Cells; D008175:Lung Neoplasms / Q000188:drug therapy*; D008727:Methotrexate / Q000627:therapeutic use; D051379:Mice; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental; D009607:Nitrosourea Compounds / Q000627:therapeutic use; D014461:Ultracentrifugation; D014747:Vinblastine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D009607:Nitrosourea Compounds; D003561:Cytarabine; D014747:Vinblastine; D003520:Cyclophosphamide; D008727:Methotrexate